Literature DB >> 15615263

Monocyte/Macrophage-specific marker CD163+ histiocytic sarcoma: case report with clinical, morphologic, immunohistochemical, and molecular genetic studies.

Makoto Mikami1, Yoshito Sadahira, Yoshimasa Suetsugu, Hideho Wada, Takashi Sugihara.   

Abstract

We report a case of a very rare disorder, histiocytic sarcoma, from a review of our autopsy cases. The neoplastic cells that proliferated in organs throughout the body were large cells containing eosinophilic cytoplasm and pleomorphic nuclei with prominent nucleoli. In the bone marrow, erythrophagocytosis by neoplastic cells was observed. The neoplastic cells were positive not only for lysozymes and CD68 (KP-1, PG-M1, and Ki-M1P) but also for a monocyte/macrophage-specific marker, CD163. In contrast, the results of tests for markers of myeloid cells, lymphoid cells, and epithelial cells were all negative. In a polymerase chain reaction study of paraffin-embedded tissues, analyses for the rearrangement of immunoglobulin heavy chain and T-cell receptor-gamma genes were negative. The current World Health Organization diagnostic criteria for histiocytic sarcoma regard immunohistochemical investigation as crucial. In this regard, the highly specific positivity for CD163 in this patient indicates that immunohistochemical staining of CD163 is very useful for the diagnosis of histiocytic sarcoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615263     DOI: 10.1532/ijh97.04064

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  22 in total

1.  Ultrastructural localization of the CD68 macrophage-associated antigen in human blood neutrophils and monocytes.

Authors:  N Saito; K A Pulford; J Breton-Gorius; J M Massé; D Y Mason; E M Cramer
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

2.  Immunohistochemical monitoring of plasmacytoid cells in lymph node sections of Kikuchi-Fujimoto disease by a new pan-macrophage antibody Ki-M1P.

Authors:  M L Hansmann; M Kikuchi; H H Wacker; H J Radzun; B N Nathwani; K Hesse; M R Parwaresch
Journal:  Hum Pathol       Date:  1992-06       Impact factor: 3.466

3.  Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163).

Authors:  P Högger; J Dreier; A Droste; F Buck; C Sorg
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

4.  Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies.

Authors:  M S Wilson; L M Weiss; K C Gatter; D Y Mason; R F Dorfman; R A Warnke
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

5.  Bone marrow findings in malignant histiocytosis and/or malignant lymphoma with concurrent hemophagocytic syndrome.

Authors:  M Takeshita; M Kikuchi; K Ohshima; K Nibu; J Suzumiya; S Hisano; Y Miyamoto; T Okamura
Journal:  Leuk Lymphoma       Date:  1993-12

Review 6.  Malignant histiocytosis associated with autoimmune thrombocytopenia.

Authors:  T Ohno; T Sugiyama; H Furukawa; T Ishibashi; M Okuma
Journal:  Am J Hematol       Date:  1994-03       Impact factor: 10.047

7.  Malignant histiocytosis with massive splenomegaly in asymptomatic patients. A possible chronic form of the disease.

Authors:  J W Vardiman; G E Byrne; H Rappaport
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

8.  PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Authors:  B Falini; L Flenghi; S Pileri; M Gambacorta; B Bigerna; H Durkop; F Eitelbach; J Thiele; R Pacini; A Cavaliere
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

10.  True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases.

Authors:  C Copie-Bergman; A C Wotherspoon; A J Norton; T C Diss; P G Isaacson
Journal:  Am J Surg Pathol       Date:  1998-11       Impact factor: 6.394

View more
  8 in total

1.  Histiocytic sarcoma with two immunohistopathologically distinct populations.

Authors:  Kanako Wakahashi; Manabu Shimoyama; Yoshio Katayama; Kentaro Minagawa; Kenji Yoshida; Ryohei Sasaki; Shunji Nakayama; Hiroshi Yokozaki; Emmy Yanagita; Tomoo Itoh; Yoshitake Hayashi; Toshimitsu Matsui
Journal:  Int J Hematol       Date:  2010-10-06       Impact factor: 2.490

2.  Aggressive sporadic histiocytic sarcoma with immunoglobulin heavy chain gene rearrangement and t(14;18).

Authors:  Eiko Hayase; Mitsutoshi Kurosawa; Masakatsu Yonezumi; Sachiko Suzuki; Hiroaki Suzuki
Journal:  Int J Hematol       Date:  2010-10-26       Impact factor: 2.490

3.  Development of myeloid sarcoma after long-term methotrexate use for rheumatoid arthritis.

Authors:  Tomomi Sakai; Shinobu Tamura; Takashi Miyoshi; Naofumi Nesumi; Kenichi Nagai; Koichi Oshima
Journal:  Int J Hematol       Date:  2014-02-07       Impact factor: 2.490

4.  Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes.

Authors:  Anuhya Kommalapati; Sri Harsha Tella; Martin Durkin; Ronald S Go; Gaurav Goyal
Journal:  Blood       Date:  2017-11-28       Impact factor: 22.113

5.  Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features.

Authors:  Shinichi Kobayashi; Fumihiko Kimura; Yukihiro Hama; Kazuto Ogura; Hiroki Torikai; Ayako Kobayashi; Takashi Ikeda; Ken Sato; Shinsuke Aida; Shigeru Kosuda; Kazuo Motoyoshi
Journal:  Int J Hematol       Date:  2007-12-01       Impact factor: 2.490

6.  Myeloid cells in cancer progression: unique subtypes and their roles in tumor growth, vascularity, and host immune suppression.

Authors:  Pampee P Young; Shidrokh Ardestani; Bin Li
Journal:  Cancer Microenviron       Date:  2010-04-20

7.  CD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma.

Authors:  Keigo Kubota; Masafumi Moriyama; Sachiko Furukawa; Haque A S M Rafiul; Yasuyuki Maruse; Teppei Jinno; Akihiko Tanaka; Miho Ohta; Noriko Ishiguro; Masaaki Yamauchi; Mizuki Sakamoto; Takashi Maehara; Jun-Nosuke Hayashida; Shintaro Kawano; Tamotsu Kiyoshima; Seiji Nakamura
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

8.  Disseminated histiocytic sarcoma with hemophagocytosis in a rabbit.

Authors:  Mio Ishimori; Masaki Michishita; Hisashi Yoshimura; Daigo Azakami; Kazuhiko Ochiai; Toshiyuki Ishiwata; Kimimasa Takahashi
Journal:  J Vet Med Sci       Date:  2017-07-21       Impact factor: 1.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.